Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: a narrative review
Abstract Background The relationship between gastrointestinal (GI) bacteria and the response to anti-CTLA-4 and anti-PD-1 immunotherapy in the treatment of cancer can potentially be enhanced to allow patients to maximally respond to these treatments. Insight into the complex interaction between gut...
Main Authors: | Peter L. Miller, Tiffany L. Carson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Gut Pathogens |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13099-020-00381-6 |
Similar Items
-
Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
by: Bolei Li, et al.
Published: (2021-09-01) -
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
by: Sally Temraz, et al.
Published: (2021-07-01) -
The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy
by: Xiangjun Liu, et al.
Published: (2021-08-01) -
Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway
by: Xinjian Xu, et al.
Published: (2020-04-01) -
Immune Checkpoint Inhibitors: Ctla-4 and Pd-1/Pd-l1 in Immunotherapy
by: Kübra KAHVECİ, et al.
Published: (2019-12-01)